INSIGHTS ON CLINICAL TRIAL DESIGN
-
5 RWE Approaches That Strengthen Precision Oncology
Real-world evidence is becoming vital in precision oncology. Discover five creative, practical ways sponsors can use RWE to fuel development, sharpen regulatory strategy, and strengthen market access.
-
Sleep Assessment In Sleep Disorders
Discover how continuous, objective monitoring in a home environment captures sleep improvements that traditional lab-based snapshots often miss, ensuring more accurate clinical outcomes.
-
You're Buying Patient And Site Services All Wrong
Centralize patient and site services under a single platform to streamline operations, reduce costs, and deliver a consistent, patient-focused experience that enhances trial performance.
-
Simultaneous Submissions And Managing Multiple Regulatory Pathways
Global regulators are increasingly aligned, creating new opportunities for sponsors to pursue near-simultaneous submissions across major markets
-
Early Immune Profiling With In Vivo, In Vitro, And Ex Vivo Systems10/7/2025
Modern biologics increasingly interact with the immune system. While these innovations enable transformative therapies, they can also provoke acute immune activation during first-in-human (FIH) trials.
-
Overcoming Barriers To Clinical Trial Participation In Oncology12/3/2024
Oncology clinical trials face unique challenges in patient recruitment and retention due to barriers such as awareness, logistical constraints, and eligibility criteria.
-
Designing Successful Cell And Gene Therapy Trials9/10/2025
Designing cell and gene therapy trials requires specialized strategies to navigate unique complexities, ensuring successful and compliant development.
-
Outlook Good For 7 Drugs Up For Q3 Review8/15/2024
A total of 24 drugs, devices, diagnostics, and deals are expected to progress in the third quarter of 2024, including approval applications for 17 drugs. The estimated overall likelihood of approval is 90% or higher for seven of those drugs, including revumenib for acute myelogenous leukemia and KarXT for schizophrenia.
-
Optimizing The Path From First-In-Human To Proof-Of-Concept2/23/2026
By collapsing the gaps between manufacturing and clinical trials and integrating these functions into a unified system, teams can adjust formulations in real-time and accelerate timelines.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Clinical trials often require travel coordination, reimbursements, and ongoing logistical support. Explore a service that centralizes those needs to help participants stay engaged.
-
Your trusted RTSM solution, PULSE is designed to support all study designs with configurable, pre-validated components. PULSE empowers study teams to easily manage randomization and trial supply workflows with flexibility and precision.
-
Veristat ensures that your clinical trial or program design supports your regulatory strategy, whether you plan to run a single pivotal trial or multiple trials.
-
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market.
-
Our network of 150+ active clinical trial sites allows us to identify potential partners that align with your therapeutic area, geographic preference, and specialty population requirements.